Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

DOI Full Paper Access

1.3K

Citations

23

References

2019

Year

Harry Heijerman, Edward F. McKone, D.G. Downey, Eva Van Braeckel, Steven M. Rowe, Elizabeth Tullis, Marcus Mall, John Welter, Bonnie W. Ramsey, Charlotte McKee,

Mendelian DisorderGeneticsIvacaftor Combination RegimenF508del MutationMedicine

References

	Year	Citations

Page 1